These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7316728

  • 1. [Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
    Schumm F, Dichgans J, Zeller E.
    Arch Psychiatr Nervenkr (1970); 1981; 230(4):315-23. PubMed ID: 7316728
    [Abstract] [Full Text] [Related]

  • 2. Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.
    Bartels M, Zeller E.
    Eur Arch Psychiatry Neurol Sci; 1984; 234(3):172-4. PubMed ID: 6489405
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H, Chien CP, Cole JO.
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of extrapyramidal motor disturbances by tiaprid (author's transl)].
    Claus D, Aschoff JC.
    Arch Psychiatr Nervenkr (1970); 1979 Apr; 227(2):151-8. PubMed ID: 44462
    [Abstract] [Full Text] [Related]

  • 5. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J.
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [Abstract] [Full Text] [Related]

  • 7. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS, Wodak J, Veale JL, Munro OR.
    Med J Aust; 1972 Nov 04; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract] [Full Text] [Related]

  • 8. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists].
    Pollak P, Gaio JM, Hommel M, Pellat J, Perret J, Chateau R.
    Rev Neurol (Paris); 1982 Nov 04; 138(5):409-13. PubMed ID: 7146725
    [Abstract] [Full Text] [Related]

  • 9. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul 04; 27(1):100-3. PubMed ID: 4555826
    [No Abstract] [Full Text] [Related]

  • 10. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr 04; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 11. Persistent phenothiazine dyskinesia treated with tetrabenazine.
    Godwin-Austen RB, Clark T.
    Br Med J; 1971 Oct 02; 4(5778):25-6. PubMed ID: 4938245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Pakkenberg H, Fog R.
    Arch Neurol; 1974 Nov 02; 31(5):352-3. PubMed ID: 4607088
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ, Ondo WG, Dashtipour K, Swope DM.
    Clin Ther; 2012 Jul 02; 34(7):1487-504. PubMed ID: 22749259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic use of tetrabenazine].
    López Del Val LJ, López-García E, Martínez-Martínez L, Santos-Lasaosa S.
    Rev Neurol; 2012 Jul 02; 48(10):523-33. PubMed ID: 19434587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.